BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:L. lactis CKDB001 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of L. lactis CKDB001\, from ClinicalTrials.g
 ov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07496021-734@assetmemo.bio
DTSTAMP:20261121T010141Z
DTSTART;VALUE=DATE:20270531
DTEND;VALUE=DATE:20270601
SUMMARY:L. lactis CKDB001: Phase na readout est. (NCT07496021)
DESCRIPTION:L. lactis CKDB001\, phase na\, Alzheimer's Disease.\nStudy: Saf
 ety and Efficacy of L. Lactis CKDB001 in Subjects With Early Alzheimer's D
 isease\nEstimated primary completion: 31 May 2027. This is a ClinicalTrial
 s.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pag
 e: https://assetmemo.bio/drug/l-lactis-ckdb001#upcoming-events\nRegistry r
 ecord: https://clinicaltrials.gov/study/NCT07496021
URL:https://assetmemo.bio/drug/l-lactis-ckdb001#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
